Terry Howlett - Ovation Science CEO Pres
| OVATF Stock | USD 0.04 0.01 40.85% |
Insider
Terry Howlett is CEO Pres of Ovation Science
| Age | 75 |
| Phone | 604 283 0903 |
| Web | https://ovationscience.com |
Ovation Science Management Efficiency
The company has return on total asset (ROA) of (0.7361) % which means that it has lost $0.7361 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.884) %, meaning that it generated substantial loss on money invested by shareholders. Ovation Science's management efficiency ratios could be used to measure how well Ovation Science manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jakob Feinstein | Curaleaf Holdings | N/A | |
| Eugene III | Biofrontera | 40 | |
| Peter JD | Curaleaf Holdings | 55 | |
| Erica CPA | Biofrontera | 39 | |
| Nilyum Jhala | Trulieve Cannabis Corp | N/A | |
| Camilo Lyon | Curaleaf Holdings | N/A | |
| Jason Pernell | Trulieve Cannabis Corp | 45 | |
| Marc MD | Rockwell Medical | 63 | |
| Linda Marsicano | Green Thumb Industries | 55 | |
| Eran Nir | Kamada | 52 | |
| Feng Zhou | China SXT Pharmaceuticals | 33 | |
| Hermann Lubbert | Biofrontera | 68 | |
| Ariella Raban | Kamada | 48 | |
| Bret Kravitz | Green Thumb Industries | 43 | |
| Jason Finkelstein | Rockwell Medical | N/A | |
| CPA CPA | Intracellular Th | 68 | |
| Edward Kremer | Curaleaf Holdings | 51 | |
| Alex CPA | Trulieve Cannabis Corp | 48 | |
| Joe Holland | Curaleaf Holdings | N/A | |
| Kimberly Rivers | Trulieve Cannabis Corp | 45 | |
| Swadheen Sehgal | Green Thumb Industries | N/A | |
Management Performance
| Return On Equity | -1.88 | |||
| Return On Asset | -0.74 |
Ovation Science Leadership Team
Elected by the shareholders, the Ovation Science's board of directors comprises two types of representatives: Ovation Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ovation. The board's role is to monitor Ovation Science's management team and ensure that shareholders' interests are well served. Ovation Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ovation Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BCom ACA, S CFO | ||
| David Ryan, Head Director | ||
| Terry Howlett, CEO Pres | ||
| Doreen McMorran, COO VP |
Ovation Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ovation Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.88 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (11.43) % | |||
| Current Valuation | 537.31 K | |||
| Shares Outstanding | 29.37 M | |||
| Shares Owned By Insiders | 28.64 % | |||
| Price To Book | 10.86 X | |||
| Price To Sales | 4.87 X | |||
| Revenue | 224.95 K | |||
| Gross Profit | 520.79 K |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Ovation Pink Sheet
Ovation Science financial ratios help investors to determine whether Ovation Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ovation with respect to the benefits of owning Ovation Science security.